Existing, Leading Technology
Zenon is a part of the Sgenia Group (“Sgenia”), a leading European sensor developer. The device will utilise existing Sgenia technology to detect the presence of MRSA/SA on both individuals and in the environment.
Sgenia is known for its cutting edge sensor development and is a supplier to the Tokamak device of a €17 billion Nuclear Fusion research project. This is a unique scientific collaboration described as “an exploration that could change the course of civilisation”, through the development of an unlimited nuclear fusion based energy source. Sgenia is a developer and supplier of the sensors, as well as of sensor technology applied to the control system. Sgenia supplied sensors detect and analyze the position of the plasma within the Tokamak device of the nuclear fusion reactor, and the Tokamak’s magnetic field is adjusted accordingly, constraining the highly unstable plasma to within a millimetre or two of its ideal position.
The sophisticated technology and software that controls the Tokamak has already been successfully adapted by Sgenia to produce an algal contamination detector for use in water supply applications. The algal sensor scans for the Volatile Organic Compounds (“VOCs”) emitted by the target algae. These form a unique “chemical signature” to rapidly and effectively determine the presence or absence of the alage. The Sgenia detector is effectively an electronic “nose” that can smell this signature. This sensor system has been sold to and has undergone a successful eighteen month trial with a Madrid area water supplier in Spain. It is likely to be rolled out as a networked solution across the water company’s operations.
Zenon will use this same technology platform for its MRSA device.